On the contrary, in an American HCC cohort ( n = 57) assessed to immunotherapy, sex-specific sarcopenia showed a trend of worse OS (HR: 1.71, 95%) but was not statistically significant ( p = 0.215) [ 64 ].
1
—
—
On the contrary, in an American HCC cohort ( n = 57) assessed to immunotherapy, sex-specific sarcopenia showed a trend of worse OS (HR: 1.71, 95%) but was not statistically significant ( p = 0.215) [ 64 ].